Research and Markets (http://www.researchandmarkets.com/research/gphbts/global_prostate) has announced the addition of the "Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2016" report to their offering.

The report provides insights into Prostate Cancer epidemiology, Prostate Cancer diagnosed patients, and Prostate Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Prostate Cancer derived from epidemiological analysis, percentage of patients diagnosed with Prostate Cancer, and percentage of patients treated with Prostate Cancer therapy.

The study helps executives estimate Prostate Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literature, government databases and other secondary sources.

Key Topics Covered:

1. Prostate Cancer: Disease Definition

2. Global Prostate Cancer Patient Flow

3. Prostate Cancer Patient Flow in the US

4. Prostate Cancer Patient Flow in Europe

5. Prostate Cancer Patient Flow in Germany

6. Prostate Cancer Patient Flow in France

7. Prostate Cancer Patient Flow in Spain

8. Prostate Cancer Patient Flow in Italy

9. Prostate Cancer Patient Flow in UK

10. Prostate Cancer Patient Flow in Japan

For more information visit http://www.researchandmarkets.com/research/gphbts/global_prostate